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Bio-hybrid artificial organs are an attractive concept to restore organ function through precise biological
cooperation with surrounding tissues in vivo. However, in bio-hybrid artificial organs, an artificial organ
with fibrous connective tissues, includingmuscles, tendons and ligaments, has not been developed. Here, we
have enveloped with embryonic dental follicle tissue around a HA-coated dental implant, and transplanted
into the lower first molar region of a murine tooth-loss model. We successfully developed a novel fibrous
connected tooth implant using a HA-coated dental implant and dental follicle stem cells as a bio-hybrid
organ. This bio-hybrid implant restored physiological functions, including bone remodelling, regeneration
of severe bone-defect and responsiveness to noxious stimuli, through regeneration with periodontal tissues,
such as periodontal ligament and cementum. Thus, this study represents the potential for a next-generation
bio-hybrid implant for tooth loss as a future bio-hybrid artificial organ replacement therapy.
O
rgan functions are achieved via biological cooperation with surrounding tissues and other organs1.
Alternative therapies using artificial organs represent an approach to partially support organ function
in vivo, but they presently are not able to entirely replace organ function2. A bio-hybrid artificial organ is
an attractive concept to restore organ function through precise biological cooperation with surrounding tissues in
vivo2,3. In the blood circulatory system, physical functions including pumping and filtration have been conven-
tionally substituted using ventricular assist devices and ex vivo dialysis systems for heart and kidney failure,
respectively2,4. In sensory organ dysfunction, bio-hybrid artificial eyes and cochlear implants have aided in the
functional restoration of visual impairment and hearing loss, respectively, via afferent neural transmission to the
central nervous system (CNS)5,6. A bio-hybrid artificial arm that is operated by efferent neural control from
the CNS has also been developed as a bio-hybrid organ for irreversible arm loss7. In the skeletal system, artificial
joints have achieved osseo-integration with bone tissue and have contributed to the support of mechanical
loading8. Fibrous connective tissues, including muscles, tendons and ligaments, play important roles in exerting
biological organ functions, such as tight connectivity, proper flexibility, mobility and resistance against mech-
anical stimulations8. However, in bio-hybrid artificial organs, a fibrous connective artificial organ has not been
structurally and functionally established, and further technological improvements are required to achieve fully
functional cooperation between an artificial organ and the surrounding tissues3,8.
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Organs, including eyes, joints and teeth, are connected to sur-
rounding tissues via fibrous connective tissues so that they can effi-
ciently perform their biological functions9. The periodontal ligament
(PDL), which is developed from the dental follicle in tooth germ, is
one of the fibrous connective tissues between the tooth-root and the
jawbone10. The PDL plays essential physiological roles in the absorp-
tion of occlusal loading and orthodontic tooth movement accom-
panied by bone remodelling, and it contributes to the functional
cooperation among the teeth, masticatory muscles and temporo-
mandibular joint under the control of the CNS11,12. After tooth loss
as a result of dental disorders such as caries, periodontal disease or
injury, tooth restoration is traditionally performed by replacement
with artificial material, such as fixed or removable dentures13,14. In
addition, an osseo-integrated dental implant that directly connects
with the alveolar bone independent of the PDL has been widely
applied for the rehabilitation of tooth loss15,16. However, current
dental implants are not adaptable to patients in the process of jaw-
bone growth and to those patients with severe bone defects11,16. It has
been therefore expected to develop a fully functional dental implant
that satisfies physiological and functional requirements, including
bone remodelling, cooperation with the maxillofacial region and
sensing of noxious stimulation through connection with a bioengi-
neered PDL as a fibrous connected bio-hybrid organ17,18.
Regenerative medicine, which developed due to our understand-
ing of embryonic development, stem cell biology and tissue engin-
eering technologies, is an attractive concept to restore organ
function19–21. Stem cell transplantation therapies have been
developed to restore the partial loss of organ functions by replacing
hematopoietic stem cells in leukaemia22 and neural stem cells in
spinal injury23. Bioengineered two-dimensional tissues have also
been used to efficiently repair diseases such as severe burn, corneal
injury and myocardial infarction24,25. Recently, advances in 3D stem
cell manipulation and culturing have been used to understand cell
differentiation, cell assembly and multicellular tissue organisation,
providing capabilities beyond those of 2D cell cultures19,26. It is
expected to further developmedical innovations using stem cells that
can regenerate for severe disorders such as extensive tissue injury or
organ dysfunction19,26. To develop a novel bio-hybrid artificial organ
that can perform all of the biological organ functions in vivo, regen-
erative medicine technologies using stem cells and culture could
improve the functions of several artificial organs27,28.
In this study, we developed a novel fibrous connected tooth
implant using a dental implant and dental follicle stem cells as a
bio-hybrid organ. The bio-hybrid implant restored physiological
functions, including bone remodelling, regeneration of critical
bone-defect and responsiveness to noxious stimulations, through
regeneration with periodontal tissues, such as cementum, PDL and
alveolar bone. Thus, this study highlights the potential of a next-
generation bio-hybrid implant for treating tooth loss as a future
bio-hybrid artificial organ replacement therapy.
Results
Periodontal tissue formation on an artificial material using dental
follicle tissue. To identify cell sources to regenerate periodontal
tissue on an artificial material, a particle of hydroxyapatite (HA),
we first investigated whether dental tissues isolated from several
tooth developmental stages have the potential to form correct
periodontal tissues, including cementum, PDL and alveolar bone,
on the HA particle in a subrenal capsule in vivo (Supplementary
Fig. 1a, b and Fig. 1a). The transplantation of a dental mesen-
chymal tissue isolated from the tooth germ at embryonic day (ED)
14.5 formed bone around the HA particle. Incomplete periodontal
tissues with bone and PDL-like fibres, but not cementum, formed
around the HA particle after transplantation with dental follicle
tissues isolated from tooth germ at postnatal day (PD) 7 and PDL
isolated from a mature tooth at PD35 (Supplementary Fig. 1c). Only
dental follicle tissue at ED18.5 was able to form the entirely correct
periodontal tissue, including cementum, PDL and alveolar bone, on
the HA surface. We further analysed the gene expression patterns
associated with periodontal tissue during the each developmental
stage (Supplementary Fig. 2a). A multi-layered gene expression
profile, including F-spondin, Periostin and Osteocalcin, which are
the markers for cementoblasts, PDL cells and osteoblasts29,
respectively, was observed in the inner, middle and outer layers,
respectively, of dental follicle tissue at ED18.5; the only stage that
was able to generate the correct periodontal structure compared with
dental tissues from other developmental stages30 (Fig. 1b, c and
Supplementary Fig. 2a, b). These results indicated that ED18.5
tooth germ-derived dental follicle tissue (ED18.5-DF) is a suitable
cell source to generate periodontal tissues, including cementum, PDL
and alveolar bone.
Transplantation of a bio-hybrid implant into a tooth loss region.
We next investigated whether a dental titanium implant in combi-
nation with ED18.5-DF could serve as a bio-hybrid implant with
periodontal tissue after engraftment in a tooth loss-region in the
adult mouse oral environment (Fig. 1a). To adhere the ED18.5-DF
to the implant and promote cementum formation, HA sputter
deposition was performed to impart biocompatibility and osteoin-
ductivity31 and to form a rough structure on the titanium implant
surface32 (Fig. 1d). The implant was enveloped with ED18.5-DF
in the correct orientation of the multi-layered DF (Fig. 1e)
and transplanted into the lower first molar region of a murine
tooth-loss model33 (Supplementary Fig. 3a, b). Micro-CT and histo-
chemical analyses revealed alveolar bone formation around the
implant, referred to osseo-integration, at 30 days after transplan-
tation of the HA-coated implant alone (Fig. 1f, g). In contrast, in
the engrafted implant with ED18.5-DF (bio-hybrid implant), the
periodontal ligament space and correct periodontal tissue structure
consisting of cementum, PDL and alveolar bone were observed on
the HA-coated implant (Fig. 1f, g). The PDL fibre structure of the
engrafted bio-hybrid implant, which was comprised of transverse
collagen fibres and longitudinal elastin fibres, was equivalent to a
natural molar tooth (Fig. 1g and Supplementary Fig. 4a, b). The
width of the formed PDL around the bio-hybrid implant was
clearly detected and comparable to that of a natural tooth
(Fig. 1h). After transplantation of bio-hybrid implant with green
fluorescence protein (GFP)-transgenic mouse-derived ED18.5-DF,
green fluorescence was clearly detectable around the implant at 30
days after transplantation (Fig. 1i and Supplementary Fig. 4c). These
results indicate that the HA-coated implant with ED18.5-DF was
able to generate periodontal tissues and could be a bio-hybrid
implant as a fibrous connective artificial organ.
Structural analysis of the periodontal tissue in the bio-hybrid
implant. Periodontal tissue plays important roles in cooperating
with the maxillofacial region through the connection with fibre
structures in the PDL11,12. Thus, we used electro mapping to
analyse the ultrastructure of the periodontal ligament on the
implant with ED18.5-DF and bone matrices. Although the osseo-
integrated implant directly connected to the surrounding alveolar
bone, the engrafted bio-hybrid implant showed that the PDL fibre
was connected to the implant surface by scanning electron micros-
copy (SEM) analysis (Fig. 2a). Transmission electron microscopy
(TEM) analysis revealed the correct cementum formation on the
surface of the bio-hybrid implant and an invasion of Sharpey’s
fibre into the cementum of the bio-hybrid implant (Fig. 2b, c).
Electron probe micro analysis revealed that in the region of the
periodontal tissues of both a natural tooth and a bio-hybrid
implant, specific elements of hard tissue, such as calcium (Ca; red)
and phosphorus (P; green), were detected at high concentrations in
the region of cementum and alveolar bone, but not in the PDL region
(EPMA; Fig. 2d, e and Supplementary Fig. 5). These results
www.nature.com/scientificreports
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Figure 1 | Engraftment of a bio-hybrid implant in a tooth loss model. (a) Schematic representation of the generative technology of bio-hybrid implant.
(Drawings by C.T.). (b) Photographs of ED18.5 tooth germ (upper) and isolated dental follicle tissue (lower). Scale bar, 100 mm. (c) Layer arrangement
indicated by in situ hybridisation analysis for the expression patterns of F-spondin (red), Periostin (green) andOsteocalcin (blue) in ED18.5 dental follicle
tissue. Scale bar, 100 mm. (d) Photographs (left) and surface analysis (right) of titanium implant and HA implant using SEM. Scale bar, 500 mm and
1.0 mm in the photographs and SEM images, respectively. (e) Merged images of a bio-hybrid dental implant using ED18.5 dental follicles isolated from
GFP transgenic mice (upper, sagittal view; lower, horizontal view). Scale bar, 500 mm. (f) Micro-CT images of an osseo-integrated implant and a bio-
hybrid implant to in sagittal section (left, centre) and horizontal section (right) at transplantation period of Day 0 and Day 30. Bio-hybrid implant images
were observed in the periodontal ligament space (arrowhead). Scale bar, 500 mm. (g) Histological analysis of a natural tooth (upper), an engrafted osseo-
integrated implant (middle) and an engrafted bio-hybrid implant (lower) at 30 days post-transplantationwas performed.HE, Azan, andResorcin-Fuschin
staining are shown. Scale bar, 500 mm in the lower magnification (left column) and 50 mm in the higher magnification (centre-left, centre-right and right
column). D, dentin; C, cementum; AB, alveolar bone; PDL, periodontal ligament; Imp, implant. (h) Measurement of the width of periodontal ligament
area. The periodontal ligament was not detected in osseo-integrated implants at 30 days post-transplantation. N, natural tooth; O, osseo-integrated
implant; B, bio-hybrid implant; N.D., Not detected. Error bars represent the standard deviation (n 5 5). *p, 0.05, **p, 0.01 (Mann-Whitney U-test).
(i) Photograph of a bio-hybrid implant using ED18.5 dental follicles isolated fromGFP transgenic mice at 30 days post-transplantation. Arrowhead, bio-
hybrid implant. Scale bar, 500 mm.
www.nature.com/scientificreports
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Figure 2 | Structural analyses of a periodontal tissue in the bio-hybrid implant. (a) Scanning electron microscopic (SEM) images of natural tooth
(upper), the engrafted osseo-integrated implant (middle) and the engrafted bio-hybrid implant (lower) at 30 days post transplantation was performed.
Scale bar, 20 mm and 1.0 mm in the lower and higher magnification, respectively. D, dentin; AB, alveolar bone; PDL, periodontal ligament; Imp, implant.
(b and c) Transmission electron microscopic (TEM) observation of a natural tooth (left) and the engrafted bio-hybrid implant (right). Formation of
lamellar cementum (b, arrowhead) and invasion of Sharpey’s fibres into the cementum (c, arrowhead). Scale bar, 500 nm. C, cementum; PDL,
periodontal ligament. (d) Amounts of calcium (Ca, red), phosphorus (P, green), and titanium (Ti, blue) in a natural tooth (top), the engrafted osseo-
integrated implant (middle) and the engrafted bio-hybrid implant (bottom), as determined by SEM. The amounts of elements were measured in the area
between dotted lines. AB, alveolar bone; PDL, periodontal ligament; Imp, implant. (e) Elementalmapping superposition of the natural tooth (top), osseo-
integrated implant (middle) and bio-hybrid implant (bottom). Calcium (Ca, red), phosphorus (P, green), titanium (Ti, blue) and merged images are
shown. AB, alveolar bone; PDL, periodontal ligament; Imp, implant.
www.nature.com/scientificreports
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demonstrated that the engrafted bio-hybrid implant formed the
correct periodontal tissue architecture on the implant surface and
the proper fibrous structural connections were formed.
Functional analysis of the periodontal ligament and nerve fibres
of the bio-hybrid implant. It has been postulated that a fibrous
connective artificial implant functioning as a bio-hybrid organ
could be achieved by fulfilling critical functions in the oral
environment, such as the cooperation of the bio-hybrid implant
with the oral and maxillofacial regions through the PDL34. There-
fore, we investigated whether an engrafted bio-hybrid implant could
restore physiological periodontal functions, specifically the response
to mechanical stress and the ability to perceive noxious stimulations
in vivo. When we analysed the orthodontic movement using a
mechanical force in an experimental tooth movement model, the
bio-hybrid implant moved in a similar manner to natural teeth in
response to orthodontic force (Fig. 3a, b). During experimental tooth
movement, colony-stimulating factor-1 (Csf-1) mRNA-positive
cells, which were used as a marker of osteoclastogenesis, and
osteocalcin (Ocn) mRNA-positive osteoblasts were observed on the
compression and tension sides, respectively33,35,36 (Fig. 3c). These
results demonstrate that the PDL of the bio-hybrid implant
successfully mediates bone remodelling via the proper localisation
of osteoclasts and osteoblasts in response to mechanical stress and
that the implant represents a fibrous connective bio-hybrid implant.
The ability to perceive noxious stimulation, including mechanical
stress and pain, are important for proper tooth function34.
Trigeminal ganglional neurons, which innervate the pulp and PDL,
can respond to these stimuli and transduce signals to the CNS. Anti-
neurofilament (NF)-immunoreactive nerve fibres were detected in
the PDL of the engrafted bio-hybrid implant (Fig. 3d). C-Fos immu-
noreactive neurons, which are detectable in the superficial layers of
the medullary dorsal horn following noxious mechanical and chem-
ical stimulation of the intraoral receptive fields, were dramatically
increased in both the natural tooth and the bio-hybrid implant at
2 hours after orthodontic treatment (Fig. 3e). These results indicate
that the engrafted bio-hybrid implant restored the ability to perceive
noxious stimulation in cooperation with the maxillofacial region.
Regeneration of a vertical bone defect by transplantation of a bio-
hybrid implant.The PDL plays an important role inmaintaining the
height and volume of the surrounding alveolar bone. Thus, tooth
root fracture and periodontal disease are known to cause
significant alveolar bone resorption37. Alveolar bone resorption
resulting from dental diseases, which is often the most drastic in
the buccal alveolar bone, makes it difficult to insert conventional
dental implants without using bone regenerative approaches38,39.
Finally, we investigated whether transplantation of the bio-hybrid
implant could regenerate not only the functional periodontal tissue
but also the surrounding alveolar bone of the recipient. To analyse
alveolar bone regeneration after implantation, we developed a critical
size bone defectmodel (3-wall bone defectmodel) that could not heal
spontaneously in themurine lower jaw. The defects were prepared by
extracting the lower first molar and then removing the buccal
alveolar bone in the lower first molar region (Fig. 4a, b and
Supplementary Fig. 6a). When the bio-hybrid implant was
transplanted into this bone defect, vertical bone formation was
observed from the marginal bone of the recipient at 14 days after
transplantation, and the bone recovered almost completely with
periodontal ligament space at 50 days after transplantation (Fig. 4c
and Supplementary Fig. 6b). The regenerative bone area after
transplantation of the bio-hybrid implant (Bio) significantly
increased compared with a no transplant control (bone defect; BD)
and a transplantation of osseo-integrated implant (OS) (BD; 57.9 6
6.5%, OS; 45.5 6 16.0%, Bio; 85.5 6 10.7%, respectively; Fig. 4d, e).
Clinically, the failure of dental implant therapy, including the loss or
vertical subsidence of the implant after treatment, causes
fundamental problems related to survival rates and subsequent
dental treatment40. After transplantation of an osseo-integrated
implant into the normal tooth loss region (OS), the subsidence of
the implant was not observed between 0 and 50 days post-implan-
tation (median: 20.04 mm, min: 0.00 mm, max: 20.05 mm).
However, transplantation of the osseo-integrated implant into the
3-wall bone defect model (OS in BD) resulted in the dramatic
subsidence of the implant (median: 20.69 mm, min: 20.25 mm,
max: 20.75 mm; Fig. 4f, g). In contrast, after transplantation of
the bio-hybrid implant into this bone defect model (Bio in BD),
the subsidence of the implant was significantly prevented (median:
20.08 mm, min: 0.00 mm, max: 20.18 mm) compared with the
osseo-integrated implants (Fig. 4f, g). These findings indicate that
the PDL on the bio-hybrid implant regenerated the critical size bone
defect and that the surrounding bone recognised the bio-hybrid
implant as an artificial tooth that was equivalent to a natural tooth.
Therefore, these results indicate that the bio-hybrid implant is a
fibrous connective bio-hybrid organ that is fully functional in vivo.
Discussion
Here, we demonstrate the successful development of a bio-hybrid
implant by using dental follicle stem cells to generate an artificial bio-
hybrid organ with fibrous connective tissue (Fig. 5). This bio-hybrid
implant restored physiological tooth functions, such as the ability to
respond to mechanical stress and the ability to perceive noxious
mechanical stimulation. The periodontal ligament present on the
bio-hybrid implant also induced vertical bone recovery in a 3-wall
bone defect model. This study demonstrates the potential for a next
generation bio-hybrid implant for treating tooth loss.
Organs maintain the proper position and functionality in vivo
through their connections to surrounding tissues via fibrous con-
nective-tissues, including tendons, ligaments and muscles9. These
fibrous connections contribute to biological mobility, such as eye
and limb movements, and alleviate mechanical load by acting as
shock absorbers9. The PDL, which is the connective fibre bundle
penetrating into the cementum and alveolar bone10, contributes to
biological tooth functions, including the reduction of excessive
occlusal loading and toothmovement, through bone remodelling11,12.
Many dental implantology studies of tooth loss have attempted to
restore periodontal tissue structure, e.g., material-based approaches
that were incorporated into the subsidence mechanism as a shock
absorber41, biochemical approaches coated by the PDL formation
inducible peptide42,43 and tissue engineering approaches using the
periodontal ligament stem cells17,18. However, these technologies
could not substitute and restore periodontal tissue functions17,18. In
this study, the bio-hybrid implant connected to the surrounding
alveolar bone through the periodontal tissues including the peri-
odontal ligament with collagen fibre and cementum, but not osseo-
integration, on the artificial dental implant surface. The bio-hybrid
implant was responsive to mechanical stress through periodontal
functions, including bone remodelling. These findings represent a
significant advancement for the therapeutic concept of bio-hybrid
artificial organs, as the biological fibrous connection achieved fully
functional coalition of the artificial organ and living tissue.
The application of artificial organs for the substitution of dysfunc-
tional organs, such as artificial eyes, cochlear implants and artificial
arms, has been limited to a condition of peripheral nerves, muscles
and bone, which can be sufficient to achieve biological activity at the
dysfunctional site5,6. To regenerate damaged tissues around the
transplantation site of artificial organ, bio-hybrid artificial organ
therapy combined with tissue-derived stem cells and multipotent
stem cells, including embryonic stem cells and induced pluripotent
stem cells, in required28. Tooth loss due to root fracture or peri-
odontal disease causes a large amount of alveolar bone resorption
in the vertical and horizontal dimensions, and conventional dental
therapies, including dental implant and autologous tooth trans-
www.nature.com/scientificreports
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Figure 3 | Functional regeneration of a bio-hybrid implant. (a and b) Horizontal superposition of micro-CT images (left) of the natural tooth (top),
osseo-integrated implant (middle) and bio-hybrid implant (bottom) at days 0 (red) and 14 days (green) of experimental orthodontic treatment. The
movement distances of tooth and both implants by orthodontic force were measured after experimental orthodontic treatment at days 0, 3, 7 and 14
(right). Data represent the mean 6 s.d.; n 5 5 for natural tooth, osseo-integrated implant and bio-hybrid implant, respectively. (c) Sections of natural
tooth, osseo-integrated and bio-hybrid implants were analysed by in situ hybridization analysis for Ocn and Csf-1 mRNA at day 6 of orthodontic
treatment.OcnmRNA-positive cells (arrowhead) andCsf-1mRNA-positive cells (arrow) are indicated. Scale bar, 100 mm. (d) Nerve fibres in the PDL of
the natural tooth (top), osseo-integrated implant (middle), and bio-hybrid implant (bottom) were analysed by immunohistochemistry using specific
antibodies for neurofilament (NF; green). Scale bar, 50 mm. D, dentin; AB, alveolar bone; PDL, periodontal ligament; Imp, implant. (e) Analysis of c-Fos
immunoreactive neurons in the medullary dorsal horns of mice after 0 hours (no stimulation, control; left) and 2 hours of stimulation by orthodontic
force (right). c-Fos protein (arrowhead) was detectable after stimulation in the natural tooth (top) and bio-hybrid implant (bottom). Scale bar, 100 mm. T,
spinal trigeminal tract.
www.nature.com/scientificreports
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Figure 4 | Alveolar bone regeneration by transplantation of a bio-hybrid implant. (a) Schematic representation of the development of a murine 3-wall
bone defect model and transplantation of the implant. (Drawings by C.T.) (b) Photographic representation of a murine 3-wall bone defect model and
transplantation of the implant. Scale bar, 500 mm. (c) Micro-CT images of vertical alveolar bone regeneration processes in the bone defect without an
implant (top), with transplantation of an osseo-integrated implant (middle) and with the transplantation of a bio-hybrid implant (bottom). Vertical bone
formation was observed with the bio-hybrid implant, and the bone had recovered almost completely 50 days after transplantation. The superior edges of
the recipient alveolar bone are indicated by a dotted line. Scale bar, 500 mm. (d) Three-dimensional superposition ofmicro-CT images for the non-treated
control (top), the osseo-integrated implant (middle) and the bio-hybrid implant (bottom) in the 3-wall bone defect at 0 (red) and 50 days (green) after
transplantation. Scale bar, 500 mm. (e) Regenerated bone area in the buccal region for the non-treated control (bone defect; BD), osseo-integrated
implant (OS) and bio-hybrid implant (Bio) after 50 days in the 3-wall bone defect model. The data are presented as the mean 6 s.d. with n 5 5 for each
experimental group. *p, 0.01 (Bonferroni test). (f) Three-dimensional frontal micro-CT images of the subsidence of the osseo-integrated implant into
normal tooth loss region (upper), osseo-integrated implant into the bone defect model (middle) and bio-hybrid implant into the bone defect model
(lower). The height to the top of the second molar cusp is indicated by the dotted line, and the top of the implant is marked by a dashed line. Scale bar,
500 mm. (g) Vertical subsidence of the osseo-integrated implants in the normal tooth loss region (OS) and in the 3-wall bone defect model (OS in BD) as
well as the bio-hybrid implants in the 3-wall bone defectmodel (Bio in BD) 50 days after transplantation. The data are presented as themedian6 s.d. with
n 5 5 for each experimental group. *p , 0.01 (Mann-Whitney U-test).
www.nature.com/scientificreports
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plantation, are difficult to apply to this clinical condition37. Although
bone regenerative therapies have been attempted, including various
utilisations of guided bone regeneration methods, autologous bone
or cell transplantation and cytokine therapies37,44, a clinical protocol
for bone regeneration has not been available yet36. In this study, we
demonstrated that a bio-hybrid implant induced vertical bone regen-
eration in a 3-wall bone defect model. These results suggest that the
surrounding tissue, including alveolar bone, recognised the bio-
hybrid implant as an equivalent organ to a natural tooth through
its connection with the periodontal tissue on the surface of the tita-
nium implant, which led to alveolar bone regeneration that was
differentiated from the outer layer of dental follicle tissue after the
transplantation. These findings indicate that transplantation of bio-
hybrid artificial organs can achieve functional restoration and have
the potential to restore the surrounding tissue via a mutual inter-
action between the bio-hybrid organ and the surrounding tissue.
Artificial organs with sensory functions, such as artificial eyes and
cochlear implants, have been successfully used to restore visual and
auditory functions via the proper afferent neurotransmission of
external signals5,6. Furthermore, bio-hybrid artificial arms substitut-
ing arm locomotorium loss can reproduce arbitrarymotions through
efferent neurotransmission to an artificial machine7. Although these
artificial therapies are effective and partially restore organ function,
further technological improvements are required to exert biological
organ functions via proper nerve innervations under the control of
the CNS5–7. Teeth are peripheral target organs for the sensory tri-
geminal and sympathetic nerves, both of which play essential roles in
tooth function and protection against noxious stimulations12,34.
Current dental implant therapies are unable to receive the noxious
stimulations due to a lack of interaction with the peripheral nerves
and the periodontal tissue15,16. To recover the neuronal perception to
mechanical forces, a next-generation bio-hybrid implant therapy
that can fully restore the periodontal tissues is needed in the near
future11. In the current study, we demonstrated that the successful
innervation into the regenerated periodontal tissues around the bio-
hybrid implant could restore responsiveness to noxious stimuli.
These findings indicate that the transplantation of bio-hybrid arti-
ficial organ has great potential for the recovery of neuronal function
via proper nerve innervations.
To realise future clinical applications of bio-hybrid implants, a
suitable cell sourcemust be identified. Current regenerative therapies
for dental disorders have used stem cells derived from wisdom teeth/
tooth germ tissue, such as the dental pulp, periodontal ligament,
apical papillae and dental follicle, which have been shown to repair
damaged tissues45–48. Currently, stem cells derived from the wisdom
tooth (impacted third molar) germ of young patients, which can
correspond to the ED18.5 dental follicle stem cells used here, are
thought to be a potential candidate for periodontal tissue regenera-
tion on a bio-hybrid implant49,50. The identification and the engin-
eering optimisation of adult tissue stem cells useful for periodontal
tissue regeneration will help develop a clinically relevant next-gen-
eration bio-hybrid implant therapy for treating tooth loss.
In conclusion, our study demonstrated a novel bio-hybrid implant
with connected fibrous tissue as a bio-hybrid organ. This study repre-
sents a significant advancement in the development of a next-gen-
eration therapeutic for the treatment of tooth loss, as this bio-hybrid
implant restored periodontal tissue structure and function through
its fibrous tissue-based connection to the surrounding tissue.
Methods
Ethics statement of animal research. C57BL/6 and C57BL/6-TgN (act-EGFP) mice
were purchased from SLC Inc., (Shizuoka, Japan). All handling and care of the mice
conformed to the National Institute of Health (NIH) guidelines for animal research,
and all experimental protocols involving animals were approved by the Tokyo
University of Science Animal Care and Use Committee (Permit Number: N13010).
All surgeries were performed under sodium pentobarbital anaesthesia, and all efforts
were made to minimise suffering.
Tissue isolation and analysis of periodontal tissue formation. We extirpated the
tooth germs at embryonic day (ED) 14.5, 18.5 and at postnatal day (PD) 7, andmature
teeth were extracted at PD35. The isolated tooth germs were incubated in 50 U/ml
dispase (BD, Franklin Lakes, NJ, USA) for 2 min at room temperature as a brief
enzymatic treatment for the separation of the dental mesenchyme, or dental follicle
tissue, from the tooth germ. After enzymatic treatment, the mesenchymal tissue and
dental follicle tissues (DF) were separated using a fine needle in Dulbecco’s modified
Eagle’s medium (D-MEM; Kohjin bio, Saitama, Japan) supplemented with 10% foetal
calf serum (GIBCO, Grand Island, NY, USA), 100 U/mL penicillin (Sigma, St. Louis,
MO, USA), 100 mg/mL streptomycin (Sigma) and 70 U/mL Deoxyribonuclease I
from bovine pancreas (DNase I; Sigma). The periodontal ligament tissues were
seceded fromPD35 in the first molar using a surgical knife. Each of the isolated tissues
were wrapped around hydroxyapatite particles (HA, CALCITITE; Hakuho, Tokyo,
Japan) of approximately 50 mm in diameter. These HA particles were placed onto a
cell culture insert (0.4 mm pore diameter; BD) and incubated at 37uC for 24 hours,
and they were transplanted into a subrenal capsule for 30 days using syngeneic
C57BL/6 mice (8 week-old, female) as the host.
In situ hybridization analysis. In situ hybridisations were performed using 10 mm
thick frozen sections. Digoxygenin-labelled probes for the specific transcripts were
prepared by PCR using primers designed from published sequences (F-spondin,
GenBank ID: NM_145584; Periostin, GenBank ID: NM_015784; Osteocalcin (OCN),
GenBank ID: NM_007541; Collagen type I (Col1), GenBank ID: NM_007742;
Collagen type XVI alpha 1 (Col16A), GenBank ID: NM_028266; Leprecan, GenBank
ID: NM_007541; Nidogen-1 (NID), GenBank ID: NM_010917; Scleraxis (Scx),
GenBank ID: NM_198885; Tenascin-N (TNN), GenBank ID: NM_177839; and
Colony-stimulating factor 1 (Csf-1), GenBank ID: NM_007778). The specific primers
for these mouse genes were as follows: F-spondin (sense, 59-AGACGGTCTACT-
GGGCACTG-39; antisense, 59-TGCAAAAGGATGTGGT GGTA-39), Periostin
(sense, 59-GGCTGAAGATGGTTCCTCTC-39; antisense, 59-CC ATGTGGCT-
GTGTAAGGCATTC-39), OCN (sense, 59-AAGCCCAGCGACTCTGAGT CT-39;
Figure 5 | Model of the connection to the periodontal tissues of a bio-hybrid implant. Schematic representation of the natural tooth, osseo-integrated
implant and bio-hybrid implant. The bio-hybrid implant restored physiological functions, including bone remodelling, regeneration of severe bone-
defect and responsiveness to noxious stimulations, through regeneration with periodontal tissues, such as cementum, PDL and alveolar bone. (Drawings
by K.N.).
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antisense, 59-CCGGAGTCTATTCACCACCTTACT-39), Col1 (sense, 59-CACT
GCAAGAACAGCGTAGC-39; antisense, 59-TTGGTTTTTGGTCACGTTCA-39),
Col16A (sense, 59-TACCTCCAGGATGCAGTTCC-39; antisense, 59-TCCTGTA-
AGCTTTGG CCATT-39), Leprecan (sense, 59-GTCACAGGCTGAGAGGAAGG-
39; antisense, 59-GC CCAGAGAAGAGTGTGTCC-39), NID (sense, 59-ACGTCA-
TGGGAATCTTCAGC-39; antisense, 59-TGCAAACCGAACTTCTGATG-39), Scx
(sense, 59-AAGAGGTGATGCC ACTAGTG-39; antisense, 59-TATACAAAAT-
TTCCAGACTTTATATTATCAT-39), TNN (sense, 59-CAAGACCTGGAACA-
GGGTGT-39; antisense, 59-TGCCTCTGTATTTCCCA ACC-39), and Csf-1 (sense,
59-TACTGAACCTGCCTGCTGAA-39; antisense, 59-CC AGAGCTTGTGA-
CAGGACA-39).We superimposed images for F-spondin, Periostin andOCN staining
using Adobe Photoshop software (Adobe Systems, San Jose, CA, USA).
Bio-hybrid implant fabrication and surface analysis. The implants were made of
pure titanium wire (Nilaco, Tokyo, Japan) with a length of 1.7 mm and a diameter of
0.6 mm, and their apical sides were shaved into a conical shape. To promote
cementum deposition around the implants, their surfaces were coated with HA,
which is biocompatible and osteoinductive, via sputter deposition32 (1–2 mm
thickness of HA; Yamahachi dentalMFG., Co., Aichi, Japan). DF tissues from ED18.5
mice were wrapped around the HA implants (5–6 tissues of each). The titanium and
HA implants were coated with platinum, and their surfaces were observed using a S-
4700 (Hitachi High-Tech, Tokyo, Japan) scanning electron microscope operated at
5 kV.
Transplantation of a bio-hybrid implant. The lower first molars of 4-week-old
C57BL/6mice were extracted under deep anaesthesia, and the resulting bone wounds
were allowed to heal for 2–3 weeks. An incision of approximately 2.0 mm in length
wasmade through the oral mucosa at the extraction site with a surgical knife to access
the alveolar bone. A dental drill (NSK, Tochigi, Japan) and root canal files (MANI,
Tochigi, Japan) were used to create a bony hole of approximately 0.8 mm in diameter
and 1.3–1.5 mm in depth in the exposed alveolar bone surface. The HA and bio-
hybrid implants were transplanted into the bony hole, and the incised oral mucosa
was sutured with 8-0 nylon (Bear Medic, Chiba, Japan). To generate a critical size
bone defect model (3-wall bone defect model) which could not heal spontaneously,
the buccal supporting alveolar bone (0.7 mm in mesiodistal width and 1.5 mm in
depth) in the lower first molar extracted region was removed using a dental drill
under deep anaesthesia. The implants were transplanted into these defects using the
same procedure described above.
Microcomputed tomography (Micro-CT).Radiographic imaging was performed by
x-ray using a Micro-CT device (R_mCT; Rigaku, Tokyo, Japan) with exposure at
90 kV and 150 mA. Micro-CT images were captured using i-view R (Morita, Kyoto,
Japan) and Imaris (Carl Zeiss, Oberkochen, Germany).
Histochemical analysis and immunohistochemistry. The tissues were excised and
immersed in 10% formalin (Mildform 10 N; Wako, Osaka, Japan). After fixation, the
tissues were decalcified in 10% sodium citrate and 22.5% formic acid for 3 days at 4uC.
Tissue sections (5–8 mm) were made after embedding paraffin and were stained with
either haematoxylin-eosin or azan. To visualise the elastic fibres, the sections were
stained with a Resorcin-fuchsin solution (Muto Pure Chemicals, Tokyo, Japan) after
10% Oxone (Wako) treatment and then counterstained with 1% Orange G (Wako).
The stained sections were observed using an Axioimager A1 microscope (Carl Zeiss)
with an AxioCAM MRc5 (Carl Zeiss) camera. For fluorescent
immunohistochemistry, 40 mm thick frozen sections were prepared and
immunostained as previously described35. The sections were incubated with a
primary antibody against the neurofilament SMI312 (151,000, mouse, Abcam,
Cambridge, MA, USA). The primary antibody was detected using a highly cross-
adsorbed Alexa FluorH 594 Goat Anti-Rabbit IgG (H 1 L) (15500, Life Technologies,
Carlsbad, CA, USA). Fluorescence microscopy images were captured using a laser
confocal microscope (LSM780; Carl Zeiss). To analyse the ability to perceive noxious
stimulation by experimental orthodontic movement, we performed c-Fos
immunohistochemistry as a pain response, which can be detected in the superficial
layers of the medullary dorsal horn located in the brainstem33,35. The sections of the
medullary dorsal horn in the brainstem region were incubated with anti-c-Fos Ab
(1510,000, Santa Cruz Biotechnology, Dallas, TX, USA). These sections were then
immunostained with peroxidase-labelled goat anti-rabbit IgG (15300, Cappel
Laboratories, Cochranville PA, USA) and PAP immune complex (153,000, Cappel).
The stained sections were observed on an Axiovert microscope (Carl Zeiss) equipped
with an AxioCAM MRc5 camera (Carl Zeiss).
Electronmicroscopy and electron probemicroanalysis. Each sample was fixed with
2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 3 hours at 4uC. For SEM
observations, samples were cut using a diamond disk and dehydrated in 100%
ethanol. After coating with platinum, the samples were examined with a S-4700 SEM
(Hitachi High-Tech) at 5 kV. For TEM analysis, the samples were post-fixed and
embedded as a previously described51. Ultrathin sections were mounted on 150 mesh
grids, stained with uranyl acetate and lead citrate and then examined by a H-7600
(Hitachi High-Tech) transmission electron microscope using an accelerating voltage
of 75 kV. An electron probe microanalyzer (EPMA-1610; Shimadzu, Kyoto, Japan)
was used for the elemental mapping of calcium (Ca), phosphorus (P), titanium (Ti),
chlorine (Cl), magnesium (Mg), sodium (Na) and potassium (K). For the elemental
analysis, undecalcified samples were embedded in epoxy resin and trimmed with
diamond disks until the sagittal plane containing the centre of the implant was
exposed. After polishing, the specimens were sputter-coated with carbon prior to
elemental analysis.
Experimental orthodontic treatments.The orthodontic treatment was performed as
described previously33,35. Experimental tooth movement was achieved with a
horizontal orthodontic force of approximately 10–15 g that was applied continuously
to the bio-hybrid implants of mice in the experimental group in the buccal direction
using a dial tension gauge (Mitsutoyo, Kanagawa, Japan) for 3, 7 or 14 days. In the
control group, the orthodontic force was applied in the buccal direction to the first
molars of 7-week-old normal C57BL/6 mice in the same manner as the experimental
group. Serial sections from day 6 samples were analysed by in situ hybridisation
analysis for macrophage colony-stimulating factor-1 (Csf-1) and osteocalcin (Ocn)
mRNA, as previously described33,35. The orthodontic movement distance of the bio-
hybrid implants and natural first molars was measured using TRI/3D-BON software
(Ratoc, Osaka, Japan).
Measurements of the regenerated bone area and subsidence distance of the
implant. To evaluate the extent of alveolar bone regeneration in our buccal bone
defect mouse model, we used a micro-CT device (Rigaku) to measure the alveolar
bone area of the treated regions at 0 and 50 days post implantation. The area of the
alveolar bone in the operated region was measured using Image J software (NIH,
Bethesda,MD, USA). The alveolar bone area at day 50was divided by the area at day 0
to calculate the regenerated bone area ratio. To analyse the subsidence of the implants
in our buccal bone defect model, we measured the subsidence distance between the
top of the second molar cusp and the top of the implant at 50 days post implantation.
The vertical subsidence of implants is presented as the median 6 standard deviation
(s.d.).
Statistical analysis. Statistical significance was determined with a Bonferroni test and
a Mann-Whitney U-test, and the data were analysed using the Common Gateway
Interface Program (twk, Saint John’s University).
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